Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Jefferies Remains a Hold on Prestige Consumer Healthcare (PBH)

Tipranks - Tipranks - Tue Oct 28, 2025

Jefferies analyst Keith Devas maintained a Hold rating on Prestige Consumer Healthcare today and set a price target of $71.00. The company’s shares closed last Friday at $62.23.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

According to TipRanks, Devas is ranked #9340 out of 10041 analysts.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Prestige Consumer Healthcare with a $80.75 average price target, implying a 29.76% upside from current levels. In a report released on October 16, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $65.00 price target.

See today’s best-performing stocks on TipRanks >>

Based on Prestige Consumer Healthcare’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $249.53 million and a net profit of $47.47 million. In comparison, last year the company earned a revenue of $267.14 million and had a net profit of $49.07 million

Read More on PBH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).